Related Experiment Videos
Detecting rare mutations associated with cancer risk.
1Department of Environmental Studies, Louisiana State University, Baton Rouge, Louisiana 70803, USA. Monster77@aol.com
American Journal of Pharmacogenomics : Genomics-Related Research in Drug Development and Clinical Practice
|June 27, 2002
Summary
Detecting rare cancer-causing mutations can predict cancer risk and relapse. Ultra-sensitive techniques show promise, but more research is needed to link genomic instability to cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Detecting rare oncogenic mutations is crucial for cancer risk assessment and monitoring disease progression.
- Tumorigenesis involves mutation accumulation and clonal evolution, offering potential for early intervention and relapse prediction.
Purpose of the Study:
- To review the development and application of ultra-sensitive mutation detection techniques for assessing cancer risk.
- To discuss the significance of genomic instability and hypermutable clones in the context of carcinogenesis.
Main Methods:
- Review of polymerase chain reaction (PCR)-based and other ultra-sensitive mutation detection techniques.
- Analysis of studies detecting single base mutations in genes like p53 and Harvey-ras.
Main Results:
- Several techniques can detect rare mutations (10^-2 to 10^-4), with some achieving detection of single base mutations at 10^-6.
- Studies have revealed mutation spectra and frequencies in human tissues, but the link to carcinogenesis remains unclear.
Conclusions:
- Ultra-sensitive mutation detection holds potential for cancer risk assessment and monitoring.
- Further rigorous epidemiological studies are needed to establish the connection between genomic instability and cancer development.